Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
2015 · Nature Communications · 198 citations
https://doi.org/10.1038/ncomms9372
M
Michael DiDonato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
3.0K
Citations
22
h-index
42
i10-index
Michael DiDonato is an academic researcher from Genomics Institute of the Novartis Research Foundation. The author has contributed to research in topics: Enzyme Structure and Function & Lung Cancer Treatments and Mutations & Biochemical and Molecular Research. The author has an h-index of 22, co-authored 80 publications.
ORCID: 0000-0002-9074-7284Papers by this author
worksA novel interleukin-10 antibody graft to treat inflammatory bowel disease
2025 · Structure · 1 citations
https://doi.org/10.1016/j.str.2024.12.010
Cryo-EM structures of Nipah virus polymerases and high-throughput RdRp assay development enable anti-NiV drug discovery
2025 · Nature Communications · 1 citations
https://doi.org/10.1038/s41467-025-61764-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat